Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Dunn

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Archives of Disease in Childhood|May 1, 1985
Congenital dislocation of the hip: early and late diagnosis and management comparedP M Dunn, R E Evans, M J Thearle, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neuronsM Liu, B F King, P M Dunn, et al.
The European Journal of Neuroscience|February 28, 2002
Changes in P2X receptor responses of sensory neurons from P2X3-deficient miceY Zhong, P M Dunn, M Bardini, et al.
Brain Research|April 5, 1991
Bradykinin evoked depolarization of a novel neuroblastoma x DRG neurone hybrid cell line (ND7/23)P M Dunn, P R Coote, J N Wood, et al.
Journal of Medical Education|August 1, 1987
A one-day communication workshop for internal medicine residentsJ F Christensen, W Levinson, J L Colligan, et al.
Journal of the American Geriatrics Society|July 1, 1996
A method to communicate patient preferences about medically indicated life-sustaining treatment in the out-of-hospital settingP M Dunn, T A Schmidt, M M Carley, et al.
Journal of Medicinal Chemistry|February 12, 2000
Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channelJ Campos Rosa, D Galanakis, A Piergentili, et al.
Journal of Medicinal Chemistry|February 17, 1995
Synthesis and structure-activity relationships of dequalinium analogues as K+ channel blockers. Investigations on the role of the charged heterocycleD Galanakis, C A Davis, B Del Rey Herrero, et al.
Annals of Internal Medicine|October 15, 1994
Medical ethics: an annotated bibliographyP M Dunn, T H Gallagher, M O Hodges, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1996
The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedilC J Roxburgh, C R Ganellin, M A Shiner, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Archives of Disease in Childhood|May 1, 1985
Congenital dislocation of the hip: early and late diagnosis and management comparedP M Dunn, R E Evans, M J Thearle, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neuronsM Liu, B F King, P M Dunn, et al.
The European Journal of Neuroscience|February 28, 2002
Changes in P2X receptor responses of sensory neurons from P2X3-deficient miceY Zhong, P M Dunn, M Bardini, et al.
Brain Research|April 5, 1991
Bradykinin evoked depolarization of a novel neuroblastoma x DRG neurone hybrid cell line (ND7/23)P M Dunn, P R Coote, J N Wood, et al.
Journal of Medical Education|August 1, 1987
A one-day communication workshop for internal medicine residentsJ F Christensen, W Levinson, J L Colligan, et al.
Journal of the American Geriatrics Society|July 1, 1996
A method to communicate patient preferences about medically indicated life-sustaining treatment in the out-of-hospital settingP M Dunn, T A Schmidt, M M Carley, et al.
Journal of Medicinal Chemistry|February 12, 2000
Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channelJ Campos Rosa, D Galanakis, A Piergentili, et al.
Journal of Medicinal Chemistry|February 17, 1995
Synthesis and structure-activity relationships of dequalinium analogues as K+ channel blockers. Investigations on the role of the charged heterocycleD Galanakis, C A Davis, B Del Rey Herrero, et al.
Annals of Internal Medicine|October 15, 1994
Medical ethics: an annotated bibliographyP M Dunn, T H Gallagher, M O Hodges, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1996
The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedilC J Roxburgh, C R Ganellin, M A Shiner, et al.
Pageof 28